Cargando…
Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network
Patients with diabetes are more likely to be infected with Coronavirus disease 2019 (COVID-19), and the risk of death is significantly higher than ordinary patients. Dipeptidyl peptidase-4 (DPP4) is one of the functional receptor of human coronavirus. Exploring the relationship between diabetes mell...
Autores principales: | Gao, Qian, Zhang, Wenjun, Li, Tingting, Yang, Guojun, Zhu, Wei, Chen, Naijun, Jin, Huawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741798/ https://www.ncbi.nlm.nih.gov/pubmed/34996987 http://dx.doi.org/10.1038/s41598-021-03912-6 |
Ejemplares similares
-
The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A meta-analysis
por: Gao, Qian, et al.
Publicado: (2021) -
The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Gao, Qian, et al.
Publicado: (2021) -
Imaging changes in patients with 2019-nCov
por: Pan, Yueying, et al.
Publicado: (2020) -
An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)
por: Tang, Biao, et al.
Publicado: (2020) -
Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
por: Rao, Praveen P. N., et al.
Publicado: (2021)